Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Eli Lilly and Company

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
56/100
Moderate Influence
$22.3M
Total Lobby Spend
6
Policy Issues
15
Lobbyists
3
Revolving Door

Eli Lilly and Company reported $22.3 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 6 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Office of Management & Budget
U.S. House of Representatives
Dept of Homeland Security
Food & Drug Administration
Dept of Agriculture
Dept of Commerce
Federal Communications Commission
Dept of Labor

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecHogan Lovells
PHATAX
4$1.6M
2024 Jul-SepJones Day
HCRGOVPHA+2
1$1.5M
2024 Apr-JunTarplin, Downs & Young
PHAHCRMED
2$1.3M
2024 Jan-MarCassidy & Associates
PHACPT
1$1.1M
2023 Oct-DecFranklin Square Group
MEDCPT
3$890K
2023 Jul-SepPrime Policy Group
HCRMEDTAX
4$1.2M
2023 Apr-JunDLA Piper
PHAHCRGOV+1
2$1.2M
2023 Jan-MarSteptoe & Johnson
GOVMED
3$1.2M

Eli Lilly and Company Lobbying FAQ

Eli Lilly and Company has spent $22.3M on federal lobbying across 6 policy areas. This includes spending on registered lobbyists and direct government contacts.

Eli Lilly and Company lobbies on 6 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Copyright/Patent/Trademark. These disclosures are filed quarterly with the Senate Office of Public Records.

Eli Lilly and Company has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Eli Lilly and Company employs 15 registered lobbyists, of whom 3 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Eli Lilly and Company has contacted 8 government entities as part of their lobbying activities, including Office of Management & Budget, U.S. House of Representatives, Dept of Homeland Security.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.